Figure 3.
(A) Elimination of daily troublesome atypical symptoms as evaluated by RSI questionnaires at 6-month follow-up. (B) PPI use before TIF and at 6-month follow-up. (C) Quality-of-life scores in patients back on some form of PPI regimen. (D) Rate of healing or reduction of reflux esophagitis in both treatment arms. (E) Elimination of daily troublesome heartburn as evaluated by GERD-HRQL questionnaires.
Abbreviations: GERD-HRQL, gastroesophageal reflux disease health-related quality of life; PPIs, proton pump inhibitors; RDQ, Reflux Disease Questionnaire; RSI, Reflux Symptom Index; TIF, transoral incisionless fundoplication.